The 3T40 activation of CLL cells caused significant resistance to ABT-199 compared to the 3T3 negative control due to the upregulation of Bcl-2 family members (Fig. 2A, B). The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.